Affibody is a private clinical-stage Swedish biotech company focused on developing into an integrated biopharma company utilizing next generation biotherapeutics based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. The company operates a focused experimental medicine model and currently has three clinical stage programs. The first two are therapeutic programs that targets psoriasis, and B-cell driven autoimmune diseases respectively. The third program is a diagnostic imaging program that is directed primarily towards metastatic breast cancer. Affibody has ongoing commercial relationships with several companies such as AbClon, Alexion, Biotest, Daewoong, Daiichi Sankyo, GE Healthcare, and Swedish Orphan Biovitrum. Affibody was founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute and is based in Stockholm, Sweden. Affibody AB is a holding of Patricia Industries.
View Top Employees from Affibody ABWebsite | http://www.affibody.com |
Employees | 121 (111 on RocketReach) |
Founded | 1998 |
Phone | +46 8 598 838 00 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology, Science and Engineering, Health Care, Health Diagnostics |
Web Rank | 37 Million |
Keywords | Biopharmaceuticals, Clinical Stage Biotechnology, Psoriasis Treatment |
Looking for a particular Affibody AB employee's phone or email?
111 people are employed at Affibody AB.